NoneCat And Horse 'In Love' TikTok Video Goes Viral | WATCH
Mark Edwards: Rich Rod deserves all the joy he could get from this meteoric three-year run
Get ready for a shave that's simply sublime! Uncover the top 5 shaving foams. From the velvety lathers to the gentle, skin-friendly products, these creams promise a clean, completely irritation-free shave every time. Stop worrying about cuts, and razor burns, and say hello to a cool, smooth, confident you! No matter if you're a novice razor or a veteran one, these amazing foams will elevate your shaving to the next level. Shaving is a customary grooming process for most of the men and a good product can be critical to get a comfortable shaving experience. In this article, we explore five popular shaving products that cater to various needs and preferences. Let's dive into their features, benefits, and one downside for each to help you make an informed choice. 1. Bombay Shaving Company Coffee Shaving Foam Image Source: Marvelof.com Order Now For all coffee lovers, the Bombay Shaving Company's Coffee Shaving Foam is nothing less than a thrill for men when shaving. It is a very unique product on the market due to the high concentration of premium coffee extracts which not only invigorate the senses but also care for the skin. This product offers a luxury shaving experience while packing both function and indulgence. Key Features 2. Gillette Classic Regular Pre-Shave Foam Image Source: Marvelof.com Order Now Gillette is a trusted name in men’s grooming, and its Classic Regular Pre-Shave Foam is a testament to why the brand remains a favorite for millions. This kind of product is aimed at people who want a stable and efficient shaving result, with sufficient quantity to make it usable for a long time. Combining the legacy of Gillette’s quality with a formulation that suits everyday needs, it’s a staple for any shaving kit. Key Features 3. Mancode Foaming Shave Gel Image Source: Marvelof.com Order Now Mancode Foaming Shave Gel is targeted toward the contemporary man who wants efficiency and prevention of skin problems. This gel brings about innovation in foaming technology that makes shaving less of a chore but a pampering experience instead. Mancode is the bridge between tradition and innovation and therefore would appeal to an individual who desires high-end grooming products. Key Features 4. The Man Company Blanc Shaving Foam Image Source: Marvelof.com Order Now For regular commuters, The Man Company Blanc Shaving Foam is the ideal companion away from home, designed for comfort and indulgence while on the move. Key Features 5. Beauty Basket GILLETTE Shaving Gel Comfort Glide Image Source: Marvelof.com Order Now Designed for ultimate comfort, the Gillette Shaving Gel Comfort Glide provides a good balance of performance and skin care. Key Features: Selecting a suitable shaving product varies according to personal preference, skin type, and grooming requirements. Bombay Shaving Company's Coffee Shaving Foam is a good product for the user who likes a strong aroma, and Gillette's Classic Foam provides outstanding value and proven quality. Mancode Foaming Gel provides skin benefits in a compact form, and The Man Company Blanc is ideal for the "frequent flyers" as a make-of-everything product. Lastly, For sensitive skin users, Gillette Comfort Glide is the most popular one. Investing in a good shaving product can elevate the grooming experience and leave you feeling confident every day. Disclaimer: The above mentioned article is a sponsored feature. This article is a paid publication and does not have journalistic/editorial involvement of IDPL, and IDPL claims no responsibility whatsoever. Stay informed on all the latest news , real-time breaking news updates, and follow all the important headlines in india news and world News on Zee News.
The aching Steelers still control their destiny in the AFC North. Their grasp, however, is slippingPep Guardiola laments Man City's inability to win games as their winless run is extended to SIX matches after surrendering a three-goal lead in the last 15 minutes against Feyenoord Manchester City threw away a three-goal lead against Feyenoord on Tuesday Pep Guardiola's winless run extended to six games after the disappointing draw Liverpool correspondent LEWIS STEELE tells all on bombshell chat with Mo Salah - LISTEN NOW to It's All Kicking Off! New episodes every Monday and Thursday By AADAM PATEL Published: 23:50 GMT, 26 November 2024 | Updated: 23:50 GMT, 26 November 2024 e-mail View comments Pep Guardiola bemoaned his Manchester City side's inability to win games after they blew a 3-0 lead against Feyenoord, to make it six games without a win in all competitions. ‘We are not able to win games, admitted Guardiola. ‘As a team, always we find a way over the years. Right now, in another situation, nothing happens.' Asked about a cut on his nose and various red marks on his head in his post-match press conference, Guardiola joked that he wanted to hurt himself as he watched his side capitulate. ‘Yes, it's from my nail on my finger,' he said. 'I cut myself with my fingernail (during the game). I want to hurt myself.’ Feyenoord scored three goals in 14 second-half minutes to stun City, who ended their five game losing streak but go into Sunday’s clash against Premier League leaders Liverpool at Anfield, without a win in over a month. ‘It was not necessary to say anything to them - they know it perfectly,’ said Guardiola, when asked what he said to his players. ‘Three episodes and they (Feyenoord) didn’t allow us to win. It is what it is and so difficult to swallow. It will be a tough season for us and we have to accept it. We have to lift them (for Anfield). I have to lift my players. It is my job.' Pep Guardiola watched on in horror as his side surrendered a three-goal advantage against Feyenoord City's winless run in all competitions extended to six games after their Etihad capitulation Feyenoord mounted an incredible comeback to recover in the final 15 minutes of the thrilling clash With City three goals up, Guardiola made a triple change in the 69th minute bringing on Kevin De Bruyne, James McAtee and Jahmai Simpson-Pusey and the City boss admitted that he thought the game was over. ‘Nathan (Ake) came off with 20 minutes left and I didn't have the feeling of a game in danger. Nathan has been injured many times. We didn’t want to expose him for 90 minutes. Ilkay (Gundogan) is the only fit holding midfielder we have and Phil (Foden) plays a lot of minutes,’ Guardiola said. ‘I did it for Kevin (De Bruyne) to get rhythm in the best way and Macca (McAtee) and Jahmai (Simpson-Pusey) are always so stable. In the moment, it was completely fine.' Asked about the boos at full-time from a section of City supporters, Guardiola insisted that he understood why. ‘They are disappointed. Of course we understand it. They come here not to remember the success in the past, but to see the team win,’ he said. The draw leaves City 15th in the Champions League standings, with eight points from five games and games against Juventus, PSG and Club Brugge remaining. City have also conceded two or more goals in six successive matches in all competitions for the first time since May 1963. Meanwhile, Feyenoord boss Brian Priske hailed his players for their mentality but insisted that City are still the best team in the world. ‘It was an unbelievable game and an unbelievable evening facing, still for me, the best team in the world, said Priske. ‘Obviously they are struggling in elements at the moment, even though they were leading 3-0. They gave away three key moments that we exploited at the end. It was a remarkable effort and mentality from our boys. After 3-1 I definitely felt that my boys were ready for this and then when they got 3-2 we felt that there was maybe something in the air tonight.’ Pep Guardiola Liverpool Share or comment on this article: Pep Guardiola laments Man City's inability to win games as their winless run is extended to SIX matches after surrendering a three-goal lead in the last 15 minutes against Feyenoord e-mail Add comment
Quantum Computing Market to Grow by USD 17.34 Billion (2024-2028), Rising Stakeholder Investments, Report on AI-Driven Market Transformation - TechnavioSoccer-Lewandowski double helps Barca to 3-0 win over Brest in Champions League
Institutional investors upbeat on outlookIMD Update: There will be heavy rain in 11 states, know IMD’s update regarding cold
Alexia Putellas scores 200th Barcelona goal'Moana 2' star Auli'i Cravalho proud to represent her culture as she returns to signature roleIsrael and Lebanon's Hezbollah agree to a ceasefire after nearly 14 months of fighting JERUSALEM (AP) — Israel has approved a ceasefire agreement with Lebanon’s Hezbollah militants, setting the stage for an end to nearly 14 months of fighting linked to the ongoing war in the Gaza Strip. The ceasefire is set to take hold at 4 a.m. local time on Wednesday. Israeli warplanes have carried out the most intense wave of strikes in Beirut and its southern suburbs since the start of the conflict amid a record number of evacuation warnings. At least 42 people were killed in strikes across Lebanon, according to local authorities. President Joe Biden said his administration now would make a renewed push for a ceasefire in Gaza. What both sides are saying about the ceasefire deal between Israel and Lebanon's Hezbollah A ceasefire deal that could end more than a year of cross-border fighting between Israel and Lebanon’s Hezbollah militant group won backing from Israeli leaders. The truce that is set to take effect early Wednesday raised hopes and renewed difficult questions in a region gripped by conflict. Hezbollah leaders also signaled tentative backing for the U.S.-brokered deal, which offers both sides an off-ramp from hostilities But the deal does little directly to resolve the much deadlier war that has raged in Gaza since Hamas militants attacked southern Israel last October. Cheap Ozempic? How millions of Americans with obesity may get access to costly weight-loss drugs WASHINGTON (AP) — Millions of obese Americans would get access to popular weekly injectables that would help them shed pounds quickly if a $35 billion proposal from the Biden administration is blessed by President-elect Donald Trump. The rule, unveiled Tuesday by the Health and Human Services Department, would require Medicare and Medicaid to cover weight-loss drugs like Wegovy or Zepbound for a large segment of Americans who are obese. But it’s unclear if the proposal, which would not go into effect until after Trump takes office, will have support from his new administration — including from Robert F. Kennedy Jr., an opponent of the drugs who has been tapped by the president-elect to serve as head of HHS. Trump vows tariffs over immigration. What the numbers say about border crossings, drugs and crime. WASHINGTON (AP) — President-elect Donald Trump is threatening tariffs on Mexico and Canada as he seeks to portray them as responsible for illegal immigration and drug smuggling. Over its tenure, the Biden administration has struggled with growing numbers of migrants arriving at the southern border. But this year, the number of people crossing the border without documents has actually been falling. That's due in part to stricter enforcement by Mexican authorities as well as asylum restrictions announced earlier this year by the Biden administration. When it comes to fentanyl smuggling, much of the deadly supply comes from Mexico though statistics show more than 86% of those sentenced for fentanyl trafficking crimes in the 12 months ending September 2023 were U.S. citizens. AP finds that a Pentagon-funded study on extremism in the military relied on old data Early this year, Pete Hegseth told a Fox News audience a new, Pentagon-funded study proved that the number of military service members and veterans involved in the Jan. 6 insurrection did not indicate a wider problem in the armed forces. Hegseth, Donald Trump's pick to head the Department of Defense, wasn’t alone. The Wall Street Journal’s opinion page highlighted the same report as evidence that extremists in military communities were “phantoms” created by a “false media narrative.” The X account for Republicans on the House Armed Services Committee posted that the study showed the focus on extremism in the military was a “witch hunt.” But The Associated Press has found that the study relied on old data, misleading analyses and ignored evidence that pointed to the opposite conclusion. How Trump's bet on voters electing him managed to silence some of his legal woes WASHINGTON (AP) — Special counsel Jack Smith move to abandon two federal cases accusing Trump of endangering American democracy and national security does away with the most serious legal threats Trump was facing as he returns to the White House. It was the culmination of a monthslong defense effort to delay the proceedings at every step and use the criminal allegations to Trump's political advantage, putting the final word in the hands of voters instead of jurors. The move just weeks after Trump’s victory over Vice President Kamala Harris underscores the immense personal stake Trump had in the campaign in which he turned his legal woes into a political rallying cry. Walmart's DEI rollback signals a profound shift in the wake of Trump's election victory NEW YORK (AP) — Walmart’s sweeping rollback of its diversity policies is the strongest indication yet of a profound shift taking hold at U.S. companies that are re-evaluating the legal and political risks associated with bold programs to bolster historically underrepresented groups in business. The changes announced by the world’s biggest retailer on Monday followed a string of legal victories by conservative groups that have filed an onslaught of lawsuits challenging corporate and federal programs aimed at elevating minority and women-owned businesses and employees. The retreat from such programs crystalized with the election of former President Donald Trump, whose administration is certain to make dismantling diversity, equity and inclusion programs a priority. Brazil’s Bolsonaro planned and participated in a 2022 coup plot, unsealed police report alleges SAO PAULO (AP) — Brazil’s former far-right President Jair Bolsonaro was fully aware of and actively participated in a coup plot to remain in office after his defeat in the 2022 election, according to a Federal Police report that has been unsealed. Brazil’s Federal Police last Thursday formally accused Bolsonaro and 36 other people of attempting a coup. They sent their 884-page report to the Supreme Court, which lifted the seal. Bolsonaro called a meeting in December 2022, during which he presented a draft decree to the commanders of the three divisions of the armed forces, that would have declared the vote fraudulent, to justify a possible military intervention. Bolsonaro has repeatedly denied any wrongdoing. New rule allows HIV-positive organ transplants People with HIV who need a kidney or liver transplant will be able to receive an organ from a donor with HIV. That's according to a new rule announced Tuesday by U.S. health officials. Previously, such transplants could be done only as part of research studies. The new rule takes effect Wednesday. It's expected to shorten the wait for organs for all, regardless of HIV status, by increasing the pool of available organs. The practice is supported by a decade of research, during which 500 transplants of kidneys and livers from HIV-positive donors have been done in the U.S. Surveillance tech advances by Biden could aid in Trump's promised crackdown on immigration President-elect Donald Trump will return to power next year with a raft of technological tools at his disposal that would help deliver his campaign promise of cracking down on immigration — among them, surveillance and artificial intelligence technology that the Biden administration already uses to help make crucial decisions in tracking, detaining and ultimately deporting immigrants lacking permanent legal status. One algorithm, for example, ranks immigrants with a “Hurricane Score,” ranging from 1-5, to assess whether someone will “abscond” from the agency’s supervision.
American Eagle Outfitters, Inc. (NYSE:AEO) Shares Acquired by Natixis Advisors LLC
Natixis Advisors LLC grew its position in shares of argenx SE ( NASDAQ:ARGX – Free Report ) by 13.0% during the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 12,014 shares of the company’s stock after buying an additional 1,379 shares during the period. Natixis Advisors LLC’s holdings in argenx were worth $6,513,000 at the end of the most recent reporting period. Several other institutional investors and hedge funds also recently made changes to their positions in the company. O Shaughnessy Asset Management LLC boosted its holdings in argenx by 32.8% in the 1st quarter. O Shaughnessy Asset Management LLC now owns 1,460 shares of the company’s stock worth $575,000 after buying an additional 361 shares during the period. Advisors Asset Management Inc. boosted its holdings in shares of argenx by 79.3% in the 1st quarter. Advisors Asset Management Inc. now owns 588 shares of the company’s stock worth $232,000 after purchasing an additional 260 shares in the last quarter. Toronto Dominion Bank grew its position in argenx by 16.5% during the first quarter. Toronto Dominion Bank now owns 303 shares of the company’s stock valued at $119,000 after acquiring an additional 43 shares during the last quarter. Silvercrest Asset Management Group LLC grew its holdings in shares of argenx by 14.2% during the 1st quarter. Silvercrest Asset Management Group LLC now owns 5,184 shares of the company’s stock valued at $2,041,000 after purchasing an additional 646 shares during the last quarter. Finally, Janus Henderson Group PLC increased its holdings in shares of argenx by 24.8% in the first quarter. Janus Henderson Group PLC now owns 2,216,648 shares of the company’s stock worth $872,690,000 after buying an additional 439,889 shares during the period. Institutional investors own 60.32% of the company’s stock. Wall Street Analysts Forecast Growth ARGX has been the topic of several analyst reports. Baird R W downgraded shares of argenx from a “strong-buy” rating to a “hold” rating in a research note on Friday, November 1st. Wedbush increased their target price on argenx from $519.00 to $560.00 and gave the stock an “outperform” rating in a research report on Friday, July 26th. Wolfe Research raised shares of argenx from a “peer perform” rating to an “outperform” rating and set a $697.00 price target for the company in a research report on Tuesday, November 12th. Oppenheimer reiterated an “outperform” rating and set a $675.00 price objective (up previously from $646.00) on shares of argenx in a research note on Thursday. Finally, Robert W. Baird cut shares of argenx from an “outperform” rating to a “neutral” rating and lifted their target price for the stock from $515.00 to $650.00 in a report on Friday, November 1st. Three research analysts have rated the stock with a hold rating, nineteen have issued a buy rating and one has assigned a strong buy rating to the company’s stock. According to MarketBeat, the company has a consensus rating of “Moderate Buy” and an average target price of $630.42. argenx Trading Up 1.5 % NASDAQ ARGX opened at $605.92 on Friday. argenx SE has a 12 month low of $327.73 and a 12 month high of $611.22. The stock has a market cap of $36.23 billion, a PE ratio of -693.08 and a beta of 0.61. The stock’s 50 day moving average is $556.37 and its 200 day moving average is $486.73. argenx ( NASDAQ:ARGX – Get Free Report ) last released its quarterly earnings data on Thursday, October 31st. The company reported $1.39 EPS for the quarter, beating the consensus estimate of $0.10 by $1.29. argenx had a negative net margin of 2.11% and a negative return on equity of 1.45%. The business had revenue of $588.88 million during the quarter, compared to the consensus estimate of $543.29 million. During the same quarter in the prior year, the firm earned ($1.25) EPS. On average, analysts forecast that argenx SE will post 2.2 EPS for the current fiscal year. argenx Company Profile ( Free Report ) argenx SE, a biotechnology company, engages in the developing of various therapies for the treatment of autoimmune diseases in the United States, Japan, Europe, Middle East, Africa, and China. Its lead product candidate is efgartigimod for the treatment of patients with myasthenia gravis, immune thrombocytopenia, pemphigus vulgaris, generalized myasthenia gravis, chronic inflammatory demyelinating polyneuropathy, thyroid eye disease, bullous pemphigoid, myositis, primary sjögren’s syndrome, post-covid postural orthostatic tachycardia syndrome, membranous nephropathy, lupus nephropathy, anca-associated vasculitis, and antibody mediated rejection; ENHANZE SC; Empasiprubart for multifocal motor neuropath, delayed graft function, and dermatomyositis; and ARGX-119 for congenital myasthenic syndrome and amyotrophic lateral sclerosis. See Also Receive News & Ratings for argenx Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for argenx and related companies with MarketBeat.com's FREE daily email newsletter .Thrivent Financial for Lutherans grew its position in PIMCO Ultra Short Government Active ETF ( NYSEARCA:BILZ – Free Report ) by 112.2% during the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 86,270 shares of the company’s stock after acquiring an additional 45,612 shares during the quarter. Thrivent Financial for Lutherans owned about 3.33% of PIMCO Ultra Short Government Active ETF worth $8,732,000 as of its most recent SEC filing. A number of other institutional investors have also recently made changes to their positions in BILZ. Beacon Capital Management LLC acquired a new position in PIMCO Ultra Short Government Active ETF during the second quarter worth about $28,000. Slagle Financial LLC purchased a new stake in shares of PIMCO Ultra Short Government Active ETF in the first quarter valued at approximately $205,000. ABLE Financial Group LLC purchased a new stake in shares of PIMCO Ultra Short Government Active ETF in the third quarter valued at approximately $238,000. Addison Capital Co purchased a new position in PIMCO Ultra Short Government Active ETF during the second quarter worth approximately $303,000. Finally, FSA Advisors Inc. purchased a new position in PIMCO Ultra Short Government Active ETF during the first quarter worth approximately $319,000. PIMCO Ultra Short Government Active ETF Stock Up 0.0 % Shares of BILZ opened at $101.14 on Friday. PIMCO Ultra Short Government Active ETF has a 52-week low of $100.59 and a 52-week high of $101.24. The stock has a fifty day simple moving average of $101.05 and a two-hundred day simple moving average of $100.97. PIMCO Ultra Short Government Active ETF Profile The PIMCO Ultra Short Government Active Exchange-Traded Fund (BILZ) is an exchange-traded fund that mostly invests in investment grade fixed income. The fund is an actively managed fund that invests in treasury bills and notes, repurchase agreements, and cash collateralized by the US government. Securities selected have a maximum maturity of six months. Featured Stories Receive News & Ratings for PIMCO Ultra Short Government Active ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PIMCO Ultra Short Government Active ETF and related companies with MarketBeat.com's FREE daily email newsletter .Eddid Financial Collaborates Again With SOAS For 10Th Anniversary International Bursary To Support Global Education
Friendly reminder |
The authenticity of this information has not been verified by this website and is for your reference only. Please do not reprint without permission. If authorized by this website, it should be used within the scope of authorization and marked with "Source: this website". |
Special attention |
Some articles on this website are reprinted from other media. The purpose of reprinting is to convey more industry information, which does not mean that this website agrees with their views and is responsible for their authenticity. Those who make comments on this website forum are responsible for their own content. This website has the right to reprint or quote on the website. The comments on the forum do not represent the views of this website. If you need to use the information provided by this website, please contact the original author. The copyright belongs to the original author. If you need to contact this website regarding copyright, please do so within 15 days. |